Hos patienter med kronisk njurinsufficiens behövs ofta en ökning av heparindosen göras under hemodialysbehandling vid behandling med NeoRecormon beroende på hematokritökningen. ###>In chronic renal failure patients an increase in heparin dose during haemodialysis is frequently required during the course of therapy with NeoRecormon as a result of the increased packed cell volume.